Service & Software
Global Recombinant Antibody Expression Service Market Research Report 2025
- Oct 04, 25
- ID: 278426
- Pages: 117
- Figures: 112
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Recombinant Antibody Expression Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Antibody Expression Service.
The Recombinant Antibody Expression Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Antibody Expression Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody Expression Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript Biotech
Creative Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Sino Biological
ProMab Biotechnologies
LakePharma(Curia)
Profacgen
Atlas Antibodies
Absolute Antibody
ProteoGenix
Rockland Immunochemicals
Proteintech
RayBiotech
BioLegend
Agilent Technologies
Novus Biologicals
OriGene Technologies
ACROBiosystems
Fitzgerald Industries(Biosynth)
Azenta Life Sciences
R&D Systems
Abnova
WuXi Biologics
Biointron Biological
Detai Bio-Tech
cusabio
FITGENE
GentleGen
TekBiotech
Segment by Type
Recombinant Protein Mammalian Expression Service
Chimeric Antibody Expression Service
Recombinant Fragment Antibody Expression Service
VHH Nanobody Expression Service
Segment by Application
Scientific Research
Immunodiagnostics
Antibody Drug Development
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Antibody Expression Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Recombinant Antibody Expression Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Antibody Expression Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody Expression Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript Biotech
Creative Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Sino Biological
ProMab Biotechnologies
LakePharma(Curia)
Profacgen
Atlas Antibodies
Absolute Antibody
ProteoGenix
Rockland Immunochemicals
Proteintech
RayBiotech
BioLegend
Agilent Technologies
Novus Biologicals
OriGene Technologies
ACROBiosystems
Fitzgerald Industries(Biosynth)
Azenta Life Sciences
R&D Systems
Abnova
WuXi Biologics
Biointron Biological
Detai Bio-Tech
cusabio
FITGENE
GentleGen
TekBiotech
Segment by Type
Recombinant Protein Mammalian Expression Service
Chimeric Antibody Expression Service
Recombinant Fragment Antibody Expression Service
VHH Nanobody Expression Service
Segment by Application
Scientific Research
Immunodiagnostics
Antibody Drug Development
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Antibody Expression Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Expression Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Recombinant Protein Mammalian Expression Service
1.2.3 Chimeric Antibody Expression Service
1.2.4 Recombinant Fragment Antibody Expression Service
1.2.5 VHH Nanobody Expression Service
1.3 Market by Application
1.3.1 Global Recombinant Antibody Expression Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Immunodiagnostics
1.3.4 Antibody Drug Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Expression Service Market Perspective (2020-2031)
2.2 Global Recombinant Antibody Expression Service Growth Trends by Region
2.2.1 Global Recombinant Antibody Expression Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Antibody Expression Service Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Antibody Expression Service Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Antibody Expression Service Market Dynamics
2.3.1 Recombinant Antibody Expression Service Industry Trends
2.3.2 Recombinant Antibody Expression Service Market Drivers
2.3.3 Recombinant Antibody Expression Service Market Challenges
2.3.4 Recombinant Antibody Expression Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Expression Service Players by Revenue
3.1.1 Global Top Recombinant Antibody Expression Service Players by Revenue (2020-2025)
3.1.2 Global Recombinant Antibody Expression Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Antibody Expression Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Antibody Expression Service Revenue
3.4 Global Recombinant Antibody Expression Service Market Concentration Ratio
3.4.1 Global Recombinant Antibody Expression Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Expression Service Revenue in 2024
3.5 Global Key Players of Recombinant Antibody Expression Service Head office and Area Served
3.6 Global Key Players of Recombinant Antibody Expression Service, Product and Application
3.7 Global Key Players of Recombinant Antibody Expression Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Expression Service Breakdown Data by Type
4.1 Global Recombinant Antibody Expression Service Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2026-2031)
5 Recombinant Antibody Expression Service Breakdown Data by Application
5.1 Global Recombinant Antibody Expression Service Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Antibody Expression Service Market Size (2020-2031)
6.2 North America Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Antibody Expression Service Market Size by Country (2020-2025)
6.4 North America Recombinant Antibody Expression Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Expression Service Market Size (2020-2031)
7.2 Europe Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Antibody Expression Service Market Size by Country (2020-2025)
7.4 Europe Recombinant Antibody Expression Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Expression Service Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Antibody Expression Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Recombinant Antibody Expression Service Market Size (2020-2031)
9.2 Latin America Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Antibody Expression Service Market Size by Country (2020-2025)
9.4 Latin America Recombinant Antibody Expression Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Expression Service Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech
11.1.1 GenScript Biotech Company Details
11.1.2 GenScript Biotech Business Overview
11.1.3 GenScript Biotech Recombinant Antibody Expression Service Introduction
11.1.4 GenScript Biotech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.1.5 GenScript Biotech Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Recombinant Antibody Expression Service Introduction
11.2.4 Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Recombinant Antibody Expression Service Introduction
11.3.4 Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Recombinant Antibody Expression Service Introduction
11.4.4 Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Sino Biological
11.5.1 Sino Biological Company Details
11.5.2 Sino Biological Business Overview
11.5.3 Sino Biological Recombinant Antibody Expression Service Introduction
11.5.4 Sino Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.5.5 Sino Biological Recent Development
11.6 ProMab Biotechnologies
11.6.1 ProMab Biotechnologies Company Details
11.6.2 ProMab Biotechnologies Business Overview
11.6.3 ProMab Biotechnologies Recombinant Antibody Expression Service Introduction
11.6.4 ProMab Biotechnologies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.6.5 ProMab Biotechnologies Recent Development
11.7 LakePharma(Curia)
11.7.1 LakePharma(Curia) Company Details
11.7.2 LakePharma(Curia) Business Overview
11.7.3 LakePharma(Curia) Recombinant Antibody Expression Service Introduction
11.7.4 LakePharma(Curia) Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.7.5 LakePharma(Curia) Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Recombinant Antibody Expression Service Introduction
11.8.4 Profacgen Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.8.5 Profacgen Recent Development
11.9 Atlas Antibodies
11.9.1 Atlas Antibodies Company Details
11.9.2 Atlas Antibodies Business Overview
11.9.3 Atlas Antibodies Recombinant Antibody Expression Service Introduction
11.9.4 Atlas Antibodies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.9.5 Atlas Antibodies Recent Development
11.10 Absolute Antibody
11.10.1 Absolute Antibody Company Details
11.10.2 Absolute Antibody Business Overview
11.10.3 Absolute Antibody Recombinant Antibody Expression Service Introduction
11.10.4 Absolute Antibody Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.10.5 Absolute Antibody Recent Development
11.11 ProteoGenix
11.11.1 ProteoGenix Company Details
11.11.2 ProteoGenix Business Overview
11.11.3 ProteoGenix Recombinant Antibody Expression Service Introduction
11.11.4 ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.11.5 ProteoGenix Recent Development
11.12 Rockland Immunochemicals
11.12.1 Rockland Immunochemicals Company Details
11.12.2 Rockland Immunochemicals Business Overview
11.12.3 Rockland Immunochemicals Recombinant Antibody Expression Service Introduction
11.12.4 Rockland Immunochemicals Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.12.5 Rockland Immunochemicals Recent Development
11.13 Proteintech
11.13.1 Proteintech Company Details
11.13.2 Proteintech Business Overview
11.13.3 Proteintech Recombinant Antibody Expression Service Introduction
11.13.4 Proteintech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.13.5 Proteintech Recent Development
11.14 RayBiotech
11.14.1 RayBiotech Company Details
11.14.2 RayBiotech Business Overview
11.14.3 RayBiotech Recombinant Antibody Expression Service Introduction
11.14.4 RayBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.14.5 RayBiotech Recent Development
11.15 BioLegend
11.15.1 BioLegend Company Details
11.15.2 BioLegend Business Overview
11.15.3 BioLegend Recombinant Antibody Expression Service Introduction
11.15.4 BioLegend Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.15.5 BioLegend Recent Development
11.16 Agilent Technologies
11.16.1 Agilent Technologies Company Details
11.16.2 Agilent Technologies Business Overview
11.16.3 Agilent Technologies Recombinant Antibody Expression Service Introduction
11.16.4 Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.16.5 Agilent Technologies Recent Development
11.17 Novus Biologicals
11.17.1 Novus Biologicals Company Details
11.17.2 Novus Biologicals Business Overview
11.17.3 Novus Biologicals Recombinant Antibody Expression Service Introduction
11.17.4 Novus Biologicals Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.17.5 Novus Biologicals Recent Development
11.18 OriGene Technologies
11.18.1 OriGene Technologies Company Details
11.18.2 OriGene Technologies Business Overview
11.18.3 OriGene Technologies Recombinant Antibody Expression Service Introduction
11.18.4 OriGene Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.18.5 OriGene Technologies Recent Development
11.19 ACROBiosystems
11.19.1 ACROBiosystems Company Details
11.19.2 ACROBiosystems Business Overview
11.19.3 ACROBiosystems Recombinant Antibody Expression Service Introduction
11.19.4 ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.19.5 ACROBiosystems Recent Development
11.20 Fitzgerald Industries(Biosynth)
11.20.1 Fitzgerald Industries(Biosynth) Company Details
11.20.2 Fitzgerald Industries(Biosynth) Business Overview
11.20.3 Fitzgerald Industries(Biosynth) Recombinant Antibody Expression Service Introduction
11.20.4 Fitzgerald Industries(Biosynth) Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.20.5 Fitzgerald Industries(Biosynth) Recent Development
11.21 Azenta Life Sciences
11.21.1 Azenta Life Sciences Company Details
11.21.2 Azenta Life Sciences Business Overview
11.21.3 Azenta Life Sciences Recombinant Antibody Expression Service Introduction
11.21.4 Azenta Life Sciences Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.21.5 Azenta Life Sciences Recent Development
11.22 R&D Systems
11.22.1 R&D Systems Company Details
11.22.2 R&D Systems Business Overview
11.22.3 R&D Systems Recombinant Antibody Expression Service Introduction
11.22.4 R&D Systems Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.22.5 R&D Systems Recent Development
11.23 Abnova
11.23.1 Abnova Company Details
11.23.2 Abnova Business Overview
11.23.3 Abnova Recombinant Antibody Expression Service Introduction
11.23.4 Abnova Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.23.5 Abnova Recent Development
11.24 WuXi Biologics
11.24.1 WuXi Biologics Company Details
11.24.2 WuXi Biologics Business Overview
11.24.3 WuXi Biologics Recombinant Antibody Expression Service Introduction
11.24.4 WuXi Biologics Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.24.5 WuXi Biologics Recent Development
11.25 Biointron Biological
11.25.1 Biointron Biological Company Details
11.25.2 Biointron Biological Business Overview
11.25.3 Biointron Biological Recombinant Antibody Expression Service Introduction
11.25.4 Biointron Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.25.5 Biointron Biological Recent Development
11.26 Detai Bio-Tech
11.26.1 Detai Bio-Tech Company Details
11.26.2 Detai Bio-Tech Business Overview
11.26.3 Detai Bio-Tech Recombinant Antibody Expression Service Introduction
11.26.4 Detai Bio-Tech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.26.5 Detai Bio-Tech Recent Development
11.27 cusabio
11.27.1 cusabio Company Details
11.27.2 cusabio Business Overview
11.27.3 cusabio Recombinant Antibody Expression Service Introduction
11.27.4 cusabio Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.27.5 cusabio Recent Development
11.28 FITGENE
11.28.1 FITGENE Company Details
11.28.2 FITGENE Business Overview
11.28.3 FITGENE Recombinant Antibody Expression Service Introduction
11.28.4 FITGENE Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.28.5 FITGENE Recent Development
11.29 GentleGen
11.29.1 GentleGen Company Details
11.29.2 GentleGen Business Overview
11.29.3 GentleGen Recombinant Antibody Expression Service Introduction
11.29.4 GentleGen Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.29.5 GentleGen Recent Development
11.30 TekBiotech
11.30.1 TekBiotech Company Details
11.30.2 TekBiotech Business Overview
11.30.3 TekBiotech Recombinant Antibody Expression Service Introduction
11.30.4 TekBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.30.5 TekBiotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Expression Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Recombinant Protein Mammalian Expression Service
1.2.3 Chimeric Antibody Expression Service
1.2.4 Recombinant Fragment Antibody Expression Service
1.2.5 VHH Nanobody Expression Service
1.3 Market by Application
1.3.1 Global Recombinant Antibody Expression Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Immunodiagnostics
1.3.4 Antibody Drug Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Expression Service Market Perspective (2020-2031)
2.2 Global Recombinant Antibody Expression Service Growth Trends by Region
2.2.1 Global Recombinant Antibody Expression Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Antibody Expression Service Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Antibody Expression Service Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Antibody Expression Service Market Dynamics
2.3.1 Recombinant Antibody Expression Service Industry Trends
2.3.2 Recombinant Antibody Expression Service Market Drivers
2.3.3 Recombinant Antibody Expression Service Market Challenges
2.3.4 Recombinant Antibody Expression Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Expression Service Players by Revenue
3.1.1 Global Top Recombinant Antibody Expression Service Players by Revenue (2020-2025)
3.1.2 Global Recombinant Antibody Expression Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Antibody Expression Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Antibody Expression Service Revenue
3.4 Global Recombinant Antibody Expression Service Market Concentration Ratio
3.4.1 Global Recombinant Antibody Expression Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Expression Service Revenue in 2024
3.5 Global Key Players of Recombinant Antibody Expression Service Head office and Area Served
3.6 Global Key Players of Recombinant Antibody Expression Service, Product and Application
3.7 Global Key Players of Recombinant Antibody Expression Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Expression Service Breakdown Data by Type
4.1 Global Recombinant Antibody Expression Service Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2026-2031)
5 Recombinant Antibody Expression Service Breakdown Data by Application
5.1 Global Recombinant Antibody Expression Service Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Antibody Expression Service Market Size (2020-2031)
6.2 North America Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Antibody Expression Service Market Size by Country (2020-2025)
6.4 North America Recombinant Antibody Expression Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Expression Service Market Size (2020-2031)
7.2 Europe Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Antibody Expression Service Market Size by Country (2020-2025)
7.4 Europe Recombinant Antibody Expression Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Expression Service Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Antibody Expression Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Recombinant Antibody Expression Service Market Size (2020-2031)
9.2 Latin America Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Antibody Expression Service Market Size by Country (2020-2025)
9.4 Latin America Recombinant Antibody Expression Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Expression Service Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Antibody Expression Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech
11.1.1 GenScript Biotech Company Details
11.1.2 GenScript Biotech Business Overview
11.1.3 GenScript Biotech Recombinant Antibody Expression Service Introduction
11.1.4 GenScript Biotech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.1.5 GenScript Biotech Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Recombinant Antibody Expression Service Introduction
11.2.4 Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Recombinant Antibody Expression Service Introduction
11.3.4 Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Recombinant Antibody Expression Service Introduction
11.4.4 Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Sino Biological
11.5.1 Sino Biological Company Details
11.5.2 Sino Biological Business Overview
11.5.3 Sino Biological Recombinant Antibody Expression Service Introduction
11.5.4 Sino Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.5.5 Sino Biological Recent Development
11.6 ProMab Biotechnologies
11.6.1 ProMab Biotechnologies Company Details
11.6.2 ProMab Biotechnologies Business Overview
11.6.3 ProMab Biotechnologies Recombinant Antibody Expression Service Introduction
11.6.4 ProMab Biotechnologies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.6.5 ProMab Biotechnologies Recent Development
11.7 LakePharma(Curia)
11.7.1 LakePharma(Curia) Company Details
11.7.2 LakePharma(Curia) Business Overview
11.7.3 LakePharma(Curia) Recombinant Antibody Expression Service Introduction
11.7.4 LakePharma(Curia) Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.7.5 LakePharma(Curia) Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Recombinant Antibody Expression Service Introduction
11.8.4 Profacgen Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.8.5 Profacgen Recent Development
11.9 Atlas Antibodies
11.9.1 Atlas Antibodies Company Details
11.9.2 Atlas Antibodies Business Overview
11.9.3 Atlas Antibodies Recombinant Antibody Expression Service Introduction
11.9.4 Atlas Antibodies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.9.5 Atlas Antibodies Recent Development
11.10 Absolute Antibody
11.10.1 Absolute Antibody Company Details
11.10.2 Absolute Antibody Business Overview
11.10.3 Absolute Antibody Recombinant Antibody Expression Service Introduction
11.10.4 Absolute Antibody Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.10.5 Absolute Antibody Recent Development
11.11 ProteoGenix
11.11.1 ProteoGenix Company Details
11.11.2 ProteoGenix Business Overview
11.11.3 ProteoGenix Recombinant Antibody Expression Service Introduction
11.11.4 ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.11.5 ProteoGenix Recent Development
11.12 Rockland Immunochemicals
11.12.1 Rockland Immunochemicals Company Details
11.12.2 Rockland Immunochemicals Business Overview
11.12.3 Rockland Immunochemicals Recombinant Antibody Expression Service Introduction
11.12.4 Rockland Immunochemicals Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.12.5 Rockland Immunochemicals Recent Development
11.13 Proteintech
11.13.1 Proteintech Company Details
11.13.2 Proteintech Business Overview
11.13.3 Proteintech Recombinant Antibody Expression Service Introduction
11.13.4 Proteintech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.13.5 Proteintech Recent Development
11.14 RayBiotech
11.14.1 RayBiotech Company Details
11.14.2 RayBiotech Business Overview
11.14.3 RayBiotech Recombinant Antibody Expression Service Introduction
11.14.4 RayBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.14.5 RayBiotech Recent Development
11.15 BioLegend
11.15.1 BioLegend Company Details
11.15.2 BioLegend Business Overview
11.15.3 BioLegend Recombinant Antibody Expression Service Introduction
11.15.4 BioLegend Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.15.5 BioLegend Recent Development
11.16 Agilent Technologies
11.16.1 Agilent Technologies Company Details
11.16.2 Agilent Technologies Business Overview
11.16.3 Agilent Technologies Recombinant Antibody Expression Service Introduction
11.16.4 Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.16.5 Agilent Technologies Recent Development
11.17 Novus Biologicals
11.17.1 Novus Biologicals Company Details
11.17.2 Novus Biologicals Business Overview
11.17.3 Novus Biologicals Recombinant Antibody Expression Service Introduction
11.17.4 Novus Biologicals Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.17.5 Novus Biologicals Recent Development
11.18 OriGene Technologies
11.18.1 OriGene Technologies Company Details
11.18.2 OriGene Technologies Business Overview
11.18.3 OriGene Technologies Recombinant Antibody Expression Service Introduction
11.18.4 OriGene Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.18.5 OriGene Technologies Recent Development
11.19 ACROBiosystems
11.19.1 ACROBiosystems Company Details
11.19.2 ACROBiosystems Business Overview
11.19.3 ACROBiosystems Recombinant Antibody Expression Service Introduction
11.19.4 ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.19.5 ACROBiosystems Recent Development
11.20 Fitzgerald Industries(Biosynth)
11.20.1 Fitzgerald Industries(Biosynth) Company Details
11.20.2 Fitzgerald Industries(Biosynth) Business Overview
11.20.3 Fitzgerald Industries(Biosynth) Recombinant Antibody Expression Service Introduction
11.20.4 Fitzgerald Industries(Biosynth) Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.20.5 Fitzgerald Industries(Biosynth) Recent Development
11.21 Azenta Life Sciences
11.21.1 Azenta Life Sciences Company Details
11.21.2 Azenta Life Sciences Business Overview
11.21.3 Azenta Life Sciences Recombinant Antibody Expression Service Introduction
11.21.4 Azenta Life Sciences Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.21.5 Azenta Life Sciences Recent Development
11.22 R&D Systems
11.22.1 R&D Systems Company Details
11.22.2 R&D Systems Business Overview
11.22.3 R&D Systems Recombinant Antibody Expression Service Introduction
11.22.4 R&D Systems Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.22.5 R&D Systems Recent Development
11.23 Abnova
11.23.1 Abnova Company Details
11.23.2 Abnova Business Overview
11.23.3 Abnova Recombinant Antibody Expression Service Introduction
11.23.4 Abnova Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.23.5 Abnova Recent Development
11.24 WuXi Biologics
11.24.1 WuXi Biologics Company Details
11.24.2 WuXi Biologics Business Overview
11.24.3 WuXi Biologics Recombinant Antibody Expression Service Introduction
11.24.4 WuXi Biologics Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.24.5 WuXi Biologics Recent Development
11.25 Biointron Biological
11.25.1 Biointron Biological Company Details
11.25.2 Biointron Biological Business Overview
11.25.3 Biointron Biological Recombinant Antibody Expression Service Introduction
11.25.4 Biointron Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.25.5 Biointron Biological Recent Development
11.26 Detai Bio-Tech
11.26.1 Detai Bio-Tech Company Details
11.26.2 Detai Bio-Tech Business Overview
11.26.3 Detai Bio-Tech Recombinant Antibody Expression Service Introduction
11.26.4 Detai Bio-Tech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.26.5 Detai Bio-Tech Recent Development
11.27 cusabio
11.27.1 cusabio Company Details
11.27.2 cusabio Business Overview
11.27.3 cusabio Recombinant Antibody Expression Service Introduction
11.27.4 cusabio Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.27.5 cusabio Recent Development
11.28 FITGENE
11.28.1 FITGENE Company Details
11.28.2 FITGENE Business Overview
11.28.3 FITGENE Recombinant Antibody Expression Service Introduction
11.28.4 FITGENE Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.28.5 FITGENE Recent Development
11.29 GentleGen
11.29.1 GentleGen Company Details
11.29.2 GentleGen Business Overview
11.29.3 GentleGen Recombinant Antibody Expression Service Introduction
11.29.4 GentleGen Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.29.5 GentleGen Recent Development
11.30 TekBiotech
11.30.1 TekBiotech Company Details
11.30.2 TekBiotech Business Overview
11.30.3 TekBiotech Recombinant Antibody Expression Service Introduction
11.30.4 TekBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025)
11.30.5 TekBiotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant Antibody Expression Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Recombinant Protein Mammalian Expression Service
Table 3. Key Players of Chimeric Antibody Expression Service
Table 4. Key Players of Recombinant Fragment Antibody Expression Service
Table 5. Key Players of VHH Nanobody Expression Service
Table 6. Global Recombinant Antibody Expression Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Recombinant Antibody Expression Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Recombinant Antibody Expression Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Recombinant Antibody Expression Service Market Share by Region (2020-2025)
Table 10. Global Recombinant Antibody Expression Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Recombinant Antibody Expression Service Market Share by Region (2026-2031)
Table 12. Recombinant Antibody Expression Service Market Trends
Table 13. Recombinant Antibody Expression Service Market Drivers
Table 14. Recombinant Antibody Expression Service Market Challenges
Table 15. Recombinant Antibody Expression Service Market Restraints
Table 16. Global Recombinant Antibody Expression Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Recombinant Antibody Expression Service Market Share by Players (2020-2025)
Table 18. Global Top Recombinant Antibody Expression Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Expression Service as of 2024)
Table 19. Ranking of Global Top Recombinant Antibody Expression Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Recombinant Antibody Expression Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Recombinant Antibody Expression Service, Headquarters and Area Served
Table 22. Global Key Players of Recombinant Antibody Expression Service, Product and Application
Table 23. Global Key Players of Recombinant Antibody Expression Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Antibody Expression Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2020-2025)
Table 27. Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2026-2031)
Table 29. Global Recombinant Antibody Expression Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Recombinant Antibody Expression Service Revenue Market Share by Application (2020-2025)
Table 31. Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Recombinant Antibody Expression Service Revenue Market Share by Application (2026-2031)
Table 33. North America Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Recombinant Antibody Expression Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. GenScript Biotech Company Details
Table 49. GenScript Biotech Business Overview
Table 50. GenScript Biotech Recombinant Antibody Expression Service Product
Table 51. GenScript Biotech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 52. GenScript Biotech Recent Development
Table 53. Creative Biolabs Company Details
Table 54. Creative Biolabs Business Overview
Table 55. Creative Biolabs Recombinant Antibody Expression Service Product
Table 56. Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 57. Creative Biolabs Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recombinant Antibody Expression Service Product
Table 61. Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Bio-Rad Laboratories Company Details
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories Recombinant Antibody Expression Service Product
Table 66. Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 67. Bio-Rad Laboratories Recent Development
Table 68. Sino Biological Company Details
Table 69. Sino Biological Business Overview
Table 70. Sino Biological Recombinant Antibody Expression Service Product
Table 71. Sino Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 72. Sino Biological Recent Development
Table 73. ProMab Biotechnologies Company Details
Table 74. ProMab Biotechnologies Business Overview
Table 75. ProMab Biotechnologies Recombinant Antibody Expression Service Product
Table 76. ProMab Biotechnologies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 77. ProMab Biotechnologies Recent Development
Table 78. LakePharma(Curia) Company Details
Table 79. LakePharma(Curia) Business Overview
Table 80. LakePharma(Curia) Recombinant Antibody Expression Service Product
Table 81. LakePharma(Curia) Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 82. LakePharma(Curia) Recent Development
Table 83. Profacgen Company Details
Table 84. Profacgen Business Overview
Table 85. Profacgen Recombinant Antibody Expression Service Product
Table 86. Profacgen Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 87. Profacgen Recent Development
Table 88. Atlas Antibodies Company Details
Table 89. Atlas Antibodies Business Overview
Table 90. Atlas Antibodies Recombinant Antibody Expression Service Product
Table 91. Atlas Antibodies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 92. Atlas Antibodies Recent Development
Table 93. Absolute Antibody Company Details
Table 94. Absolute Antibody Business Overview
Table 95. Absolute Antibody Recombinant Antibody Expression Service Product
Table 96. Absolute Antibody Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 97. Absolute Antibody Recent Development
Table 98. ProteoGenix Company Details
Table 99. ProteoGenix Business Overview
Table 100. ProteoGenix Recombinant Antibody Expression Service Product
Table 101. ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 102. ProteoGenix Recent Development
Table 103. Rockland Immunochemicals Company Details
Table 104. Rockland Immunochemicals Business Overview
Table 105. Rockland Immunochemicals Recombinant Antibody Expression Service Product
Table 106. Rockland Immunochemicals Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 107. Rockland Immunochemicals Recent Development
Table 108. Proteintech Company Details
Table 109. Proteintech Business Overview
Table 110. Proteintech Recombinant Antibody Expression Service Product
Table 111. Proteintech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 112. Proteintech Recent Development
Table 113. RayBiotech Company Details
Table 114. RayBiotech Business Overview
Table 115. RayBiotech Recombinant Antibody Expression Service Product
Table 116. RayBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 117. RayBiotech Recent Development
Table 118. BioLegend Company Details
Table 119. BioLegend Business Overview
Table 120. BioLegend Recombinant Antibody Expression Service Product
Table 121. BioLegend Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 122. BioLegend Recent Development
Table 123. Agilent Technologies Company Details
Table 124. Agilent Technologies Business Overview
Table 125. Agilent Technologies Recombinant Antibody Expression Service Product
Table 126. Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 127. Agilent Technologies Recent Development
Table 128. Novus Biologicals Company Details
Table 129. Novus Biologicals Business Overview
Table 130. Novus Biologicals Recombinant Antibody Expression Service Product
Table 131. Novus Biologicals Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 132. Novus Biologicals Recent Development
Table 133. OriGene Technologies Company Details
Table 134. OriGene Technologies Business Overview
Table 135. OriGene Technologies Recombinant Antibody Expression Service Product
Table 136. OriGene Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 137. OriGene Technologies Recent Development
Table 138. ACROBiosystems Company Details
Table 139. ACROBiosystems Business Overview
Table 140. ACROBiosystems Recombinant Antibody Expression Service Product
Table 141. ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 142. ACROBiosystems Recent Development
Table 143. Fitzgerald Industries(Biosynth) Company Details
Table 144. Fitzgerald Industries(Biosynth) Business Overview
Table 145. Fitzgerald Industries(Biosynth) Recombinant Antibody Expression Service Product
Table 146. Fitzgerald Industries(Biosynth) Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 147. Fitzgerald Industries(Biosynth) Recent Development
Table 148. Azenta Life Sciences Company Details
Table 149. Azenta Life Sciences Business Overview
Table 150. Azenta Life Sciences Recombinant Antibody Expression Service Product
Table 151. Azenta Life Sciences Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 152. Azenta Life Sciences Recent Development
Table 153. R&D Systems Company Details
Table 154. R&D Systems Business Overview
Table 155. R&D Systems Recombinant Antibody Expression Service Product
Table 156. R&D Systems Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 157. R&D Systems Recent Development
Table 158. Abnova Company Details
Table 159. Abnova Business Overview
Table 160. Abnova Recombinant Antibody Expression Service Product
Table 161. Abnova Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 162. Abnova Recent Development
Table 163. WuXi Biologics Company Details
Table 164. WuXi Biologics Business Overview
Table 165. WuXi Biologics Recombinant Antibody Expression Service Product
Table 166. WuXi Biologics Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 167. WuXi Biologics Recent Development
Table 168. Biointron Biological Company Details
Table 169. Biointron Biological Business Overview
Table 170. Biointron Biological Recombinant Antibody Expression Service Product
Table 171. Biointron Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 172. Biointron Biological Recent Development
Table 173. Detai Bio-Tech Company Details
Table 174. Detai Bio-Tech Business Overview
Table 175. Detai Bio-Tech Recombinant Antibody Expression Service Product
Table 176. Detai Bio-Tech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 177. Detai Bio-Tech Recent Development
Table 178. cusabio Company Details
Table 179. cusabio Business Overview
Table 180. cusabio Recombinant Antibody Expression Service Product
Table 181. cusabio Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 182. cusabio Recent Development
Table 183. FITGENE Company Details
Table 184. FITGENE Business Overview
Table 185. FITGENE Recombinant Antibody Expression Service Product
Table 186. FITGENE Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 187. FITGENE Recent Development
Table 188. GentleGen Company Details
Table 189. GentleGen Business Overview
Table 190. GentleGen Recombinant Antibody Expression Service Product
Table 191. GentleGen Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 192. GentleGen Recent Development
Table 193. TekBiotech Company Details
Table 194. TekBiotech Business Overview
Table 195. TekBiotech Recombinant Antibody Expression Service Product
Table 196. TekBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 197. TekBiotech Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Recombinant Antibody Expression Service Picture
Figure 2. Global Recombinant Antibody Expression Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Antibody Expression Service Market Share by Type: 2024 VS 2031
Figure 4. Recombinant Protein Mammalian Expression Service Features
Figure 5. Chimeric Antibody Expression Service Features
Figure 6. Recombinant Fragment Antibody Expression Service Features
Figure 7. VHH Nanobody Expression Service Features
Figure 8. Global Recombinant Antibody Expression Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Recombinant Antibody Expression Service Market Share by Application: 2024 VS 2031
Figure 10. Scientific Research Case Studies
Figure 11. Immunodiagnostics Case Studies
Figure 12. Antibody Drug Development Case Studies
Figure 13. Others Case Studies
Figure 14. Recombinant Antibody Expression Service Report Years Considered
Figure 15. Global Recombinant Antibody Expression Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Recombinant Antibody Expression Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Recombinant Antibody Expression Service Market Share by Region: 2024 VS 2031
Figure 18. Global Recombinant Antibody Expression Service Market Share by Players in 2024
Figure 19. Global Recombinant Antibody Expression Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Antibody Expression Service Revenue in 2024
Figure 21. North America Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 23. United States Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Recombinant Antibody Expression Service Market Share by Region (2020-2031)
Figure 35. China Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 43. Mexico Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 47. Israel Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GenScript Biotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 51. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 54. Sino Biological Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 55. ProMab Biotechnologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 56. LakePharma(Curia) Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 57. Profacgen Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 58. Atlas Antibodies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 59. Absolute Antibody Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 60. ProteoGenix Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 61. Rockland Immunochemicals Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 62. Proteintech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 63. RayBiotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 64. BioLegend Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 65. Agilent Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 66. Novus Biologicals Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 67. OriGene Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 68. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 69. Fitzgerald Industries(Biosynth) Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 70. Azenta Life Sciences Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 71. R&D Systems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 72. Abnova Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 73. WuXi Biologics Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 74. Biointron Biological Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 75. Detai Bio-Tech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 76. cusabio Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 77. FITGENE Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 78. GentleGen Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 79. TekBiotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Table 1. Global Recombinant Antibody Expression Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Recombinant Protein Mammalian Expression Service
Table 3. Key Players of Chimeric Antibody Expression Service
Table 4. Key Players of Recombinant Fragment Antibody Expression Service
Table 5. Key Players of VHH Nanobody Expression Service
Table 6. Global Recombinant Antibody Expression Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Recombinant Antibody Expression Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Recombinant Antibody Expression Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Recombinant Antibody Expression Service Market Share by Region (2020-2025)
Table 10. Global Recombinant Antibody Expression Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Recombinant Antibody Expression Service Market Share by Region (2026-2031)
Table 12. Recombinant Antibody Expression Service Market Trends
Table 13. Recombinant Antibody Expression Service Market Drivers
Table 14. Recombinant Antibody Expression Service Market Challenges
Table 15. Recombinant Antibody Expression Service Market Restraints
Table 16. Global Recombinant Antibody Expression Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Recombinant Antibody Expression Service Market Share by Players (2020-2025)
Table 18. Global Top Recombinant Antibody Expression Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Expression Service as of 2024)
Table 19. Ranking of Global Top Recombinant Antibody Expression Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Recombinant Antibody Expression Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Recombinant Antibody Expression Service, Headquarters and Area Served
Table 22. Global Key Players of Recombinant Antibody Expression Service, Product and Application
Table 23. Global Key Players of Recombinant Antibody Expression Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Antibody Expression Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2020-2025)
Table 27. Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2026-2031)
Table 29. Global Recombinant Antibody Expression Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Recombinant Antibody Expression Service Revenue Market Share by Application (2020-2025)
Table 31. Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Recombinant Antibody Expression Service Revenue Market Share by Application (2026-2031)
Table 33. North America Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Recombinant Antibody Expression Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Recombinant Antibody Expression Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Recombinant Antibody Expression Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. GenScript Biotech Company Details
Table 49. GenScript Biotech Business Overview
Table 50. GenScript Biotech Recombinant Antibody Expression Service Product
Table 51. GenScript Biotech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 52. GenScript Biotech Recent Development
Table 53. Creative Biolabs Company Details
Table 54. Creative Biolabs Business Overview
Table 55. Creative Biolabs Recombinant Antibody Expression Service Product
Table 56. Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 57. Creative Biolabs Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recombinant Antibody Expression Service Product
Table 61. Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Bio-Rad Laboratories Company Details
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories Recombinant Antibody Expression Service Product
Table 66. Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 67. Bio-Rad Laboratories Recent Development
Table 68. Sino Biological Company Details
Table 69. Sino Biological Business Overview
Table 70. Sino Biological Recombinant Antibody Expression Service Product
Table 71. Sino Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 72. Sino Biological Recent Development
Table 73. ProMab Biotechnologies Company Details
Table 74. ProMab Biotechnologies Business Overview
Table 75. ProMab Biotechnologies Recombinant Antibody Expression Service Product
Table 76. ProMab Biotechnologies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 77. ProMab Biotechnologies Recent Development
Table 78. LakePharma(Curia) Company Details
Table 79. LakePharma(Curia) Business Overview
Table 80. LakePharma(Curia) Recombinant Antibody Expression Service Product
Table 81. LakePharma(Curia) Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 82. LakePharma(Curia) Recent Development
Table 83. Profacgen Company Details
Table 84. Profacgen Business Overview
Table 85. Profacgen Recombinant Antibody Expression Service Product
Table 86. Profacgen Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 87. Profacgen Recent Development
Table 88. Atlas Antibodies Company Details
Table 89. Atlas Antibodies Business Overview
Table 90. Atlas Antibodies Recombinant Antibody Expression Service Product
Table 91. Atlas Antibodies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 92. Atlas Antibodies Recent Development
Table 93. Absolute Antibody Company Details
Table 94. Absolute Antibody Business Overview
Table 95. Absolute Antibody Recombinant Antibody Expression Service Product
Table 96. Absolute Antibody Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 97. Absolute Antibody Recent Development
Table 98. ProteoGenix Company Details
Table 99. ProteoGenix Business Overview
Table 100. ProteoGenix Recombinant Antibody Expression Service Product
Table 101. ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 102. ProteoGenix Recent Development
Table 103. Rockland Immunochemicals Company Details
Table 104. Rockland Immunochemicals Business Overview
Table 105. Rockland Immunochemicals Recombinant Antibody Expression Service Product
Table 106. Rockland Immunochemicals Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 107. Rockland Immunochemicals Recent Development
Table 108. Proteintech Company Details
Table 109. Proteintech Business Overview
Table 110. Proteintech Recombinant Antibody Expression Service Product
Table 111. Proteintech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 112. Proteintech Recent Development
Table 113. RayBiotech Company Details
Table 114. RayBiotech Business Overview
Table 115. RayBiotech Recombinant Antibody Expression Service Product
Table 116. RayBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 117. RayBiotech Recent Development
Table 118. BioLegend Company Details
Table 119. BioLegend Business Overview
Table 120. BioLegend Recombinant Antibody Expression Service Product
Table 121. BioLegend Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 122. BioLegend Recent Development
Table 123. Agilent Technologies Company Details
Table 124. Agilent Technologies Business Overview
Table 125. Agilent Technologies Recombinant Antibody Expression Service Product
Table 126. Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 127. Agilent Technologies Recent Development
Table 128. Novus Biologicals Company Details
Table 129. Novus Biologicals Business Overview
Table 130. Novus Biologicals Recombinant Antibody Expression Service Product
Table 131. Novus Biologicals Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 132. Novus Biologicals Recent Development
Table 133. OriGene Technologies Company Details
Table 134. OriGene Technologies Business Overview
Table 135. OriGene Technologies Recombinant Antibody Expression Service Product
Table 136. OriGene Technologies Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 137. OriGene Technologies Recent Development
Table 138. ACROBiosystems Company Details
Table 139. ACROBiosystems Business Overview
Table 140. ACROBiosystems Recombinant Antibody Expression Service Product
Table 141. ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 142. ACROBiosystems Recent Development
Table 143. Fitzgerald Industries(Biosynth) Company Details
Table 144. Fitzgerald Industries(Biosynth) Business Overview
Table 145. Fitzgerald Industries(Biosynth) Recombinant Antibody Expression Service Product
Table 146. Fitzgerald Industries(Biosynth) Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 147. Fitzgerald Industries(Biosynth) Recent Development
Table 148. Azenta Life Sciences Company Details
Table 149. Azenta Life Sciences Business Overview
Table 150. Azenta Life Sciences Recombinant Antibody Expression Service Product
Table 151. Azenta Life Sciences Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 152. Azenta Life Sciences Recent Development
Table 153. R&D Systems Company Details
Table 154. R&D Systems Business Overview
Table 155. R&D Systems Recombinant Antibody Expression Service Product
Table 156. R&D Systems Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 157. R&D Systems Recent Development
Table 158. Abnova Company Details
Table 159. Abnova Business Overview
Table 160. Abnova Recombinant Antibody Expression Service Product
Table 161. Abnova Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 162. Abnova Recent Development
Table 163. WuXi Biologics Company Details
Table 164. WuXi Biologics Business Overview
Table 165. WuXi Biologics Recombinant Antibody Expression Service Product
Table 166. WuXi Biologics Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 167. WuXi Biologics Recent Development
Table 168. Biointron Biological Company Details
Table 169. Biointron Biological Business Overview
Table 170. Biointron Biological Recombinant Antibody Expression Service Product
Table 171. Biointron Biological Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 172. Biointron Biological Recent Development
Table 173. Detai Bio-Tech Company Details
Table 174. Detai Bio-Tech Business Overview
Table 175. Detai Bio-Tech Recombinant Antibody Expression Service Product
Table 176. Detai Bio-Tech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 177. Detai Bio-Tech Recent Development
Table 178. cusabio Company Details
Table 179. cusabio Business Overview
Table 180. cusabio Recombinant Antibody Expression Service Product
Table 181. cusabio Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 182. cusabio Recent Development
Table 183. FITGENE Company Details
Table 184. FITGENE Business Overview
Table 185. FITGENE Recombinant Antibody Expression Service Product
Table 186. FITGENE Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 187. FITGENE Recent Development
Table 188. GentleGen Company Details
Table 189. GentleGen Business Overview
Table 190. GentleGen Recombinant Antibody Expression Service Product
Table 191. GentleGen Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 192. GentleGen Recent Development
Table 193. TekBiotech Company Details
Table 194. TekBiotech Business Overview
Table 195. TekBiotech Recombinant Antibody Expression Service Product
Table 196. TekBiotech Revenue in Recombinant Antibody Expression Service Business (2020-2025) & (US$ Million)
Table 197. TekBiotech Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Recombinant Antibody Expression Service Picture
Figure 2. Global Recombinant Antibody Expression Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Antibody Expression Service Market Share by Type: 2024 VS 2031
Figure 4. Recombinant Protein Mammalian Expression Service Features
Figure 5. Chimeric Antibody Expression Service Features
Figure 6. Recombinant Fragment Antibody Expression Service Features
Figure 7. VHH Nanobody Expression Service Features
Figure 8. Global Recombinant Antibody Expression Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Recombinant Antibody Expression Service Market Share by Application: 2024 VS 2031
Figure 10. Scientific Research Case Studies
Figure 11. Immunodiagnostics Case Studies
Figure 12. Antibody Drug Development Case Studies
Figure 13. Others Case Studies
Figure 14. Recombinant Antibody Expression Service Report Years Considered
Figure 15. Global Recombinant Antibody Expression Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Recombinant Antibody Expression Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Recombinant Antibody Expression Service Market Share by Region: 2024 VS 2031
Figure 18. Global Recombinant Antibody Expression Service Market Share by Players in 2024
Figure 19. Global Recombinant Antibody Expression Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Antibody Expression Service Revenue in 2024
Figure 21. North America Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 23. United States Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Recombinant Antibody Expression Service Market Share by Region (2020-2031)
Figure 35. China Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 43. Mexico Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Recombinant Antibody Expression Service Market Share by Country (2020-2031)
Figure 47. Israel Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Recombinant Antibody Expression Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GenScript Biotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 51. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 54. Sino Biological Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 55. ProMab Biotechnologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 56. LakePharma(Curia) Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 57. Profacgen Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 58. Atlas Antibodies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 59. Absolute Antibody Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 60. ProteoGenix Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 61. Rockland Immunochemicals Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 62. Proteintech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 63. RayBiotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 64. BioLegend Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 65. Agilent Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 66. Novus Biologicals Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 67. OriGene Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 68. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 69. Fitzgerald Industries(Biosynth) Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 70. Azenta Life Sciences Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 71. R&D Systems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 72. Abnova Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 73. WuXi Biologics Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 74. Biointron Biological Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 75. Detai Bio-Tech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 76. cusabio Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 77. FITGENE Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 78. GentleGen Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 79. TekBiotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2020-2025)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232